Clinical Trial

Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation

Completed
View on ClinicalTrials.gov →
Summary
Main evaluation of glistening at least 24 Months post-IOL implantation
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-09; most recent amendment 2026-01-15.
Status change: Not Yet Recruiting → Completed 2026-01-15
Trial Details
NCT Number NCT07297719
Lead Sponsor Carl Zeiss Meditec AG
Conditions Cataract Senile
Enrollment 33 participants
Start Date 2025-12-25
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-16